SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

The Department of Health has announced a vaccination drive against Mpox disease, as the number of laboratory-confirmed cases ...

By Juliet Aguiar DUGBARTEY, TakoradiThe Western Regional Health Directorate has confirmed 97 Mpox cases out of 387 suspected infections reported between January and July 12, 2025.A situation report ...

Yap Boum, PhD, MPH, deputy incident manager for Africa CDC's mpox response, said Mozambique's three cases involve two men and one woman, none of whom had traveled recently, suggesting that ...

Ghana has recorded 11 new Mpox cases as of July 11, bringing the total confirmed cases to 197. The Ghana Health Service (GHS) says the numbers show a steady but manageable rise, underscoring the need ...

European Medicines Agency Supports Streamlined Development Pathway for GEO-MVA Vaccine Candidate via a Single Phase 3 ...

Around 10 500 mpox vaccines will be rolled out, the Department of Health has said. The vaccines have been supplied by the ...

The Department of Health (DoH) is embarking on a vaccination drive against mpox, targeting Gauteng, the Western Cape and ...

The Health Department has warned that the number of laboratory-confirmed cases of mpox is gradually rising in the country.

Shelton, Connecticut Thursday, July 17, 2025, 18:00 Hrs [IST] ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Mpox is an infection caused by the monkeypox virus, a zoonotic disease that causes a painful, bumpy rash. It can be spread ...